Skip to main content

Stay safe, all!

Your wellbeing is important. Here are some tips to help you through COVID isolation.

Stay fit and active at home

Pesky bush ticks could be key to saving lives in world-first HRI research

28th September, 2021

HRI is on the cusp of developing a drug to save people from deadly strokes using a common Australian bush tick.

Read more

Cardiometabolic Disease Group publishes review on heart failure models

8th September, 2021

The Cardiometabolic Disease Group at HRI has published a much-needed review on models of heart failure with preserved ejection fraction (HFpEF).

Read more

PhD student Paraskevi Morris speaks at CSANZ

3rd September, 2021

PhD student Paraskevi (Evi) Morris recently spoke at the 69th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand (CSANZ) 2021.

Read more

Making cardiovascular medical devices safer

2nd September, 2021

Dr Anna Waterhouse is investigating how vital medical devices, such as those used in heart surgery, can be made safer for patients.

Read more

HRI investigates link between AstraZeneca COVID-19 vaccine and blood clots

2nd August, 2021

In an Australian first, a pilot study will seek to find biomarkers for blood clot risks in patients who have been given the AstraZeneca COVID-19 vaccine.

Read more

Global media interest in HRI’s world-first stroke drug trial

18th July, 2021

HRI researchers led by Professor Shaun Jackson have developed an anti-clotting drug that offers new hope to stroke sufferers.

Read more

Groundbreaking world-first trial offers new hope to stroke sufferers

17th July, 2021

HRI's top stroke experts are leading a world-first trial which could be a game-changer when it comes to debilitating strokes.

Read more

Dr Jessica Maclean awarded THANZ grant

7th July, 2021

Dr Jessica Maclean has been awarded a THANZ Scientific & Education Trust Grant to further investigate novel antiplatelet strategies to enhance stroke treatment.

Read more

Dr Ashish Misra awarded second Perpetual IMPACT grant

2nd July, 2021

Dr Ashish Misra was recently awarded his second Perpetual IMPACT grant. Dr Misra’s research focuses on improved understanding and potential treatment of atherosclerosis.

Read more

Support HRI

Today's research is tomorrow's cure.

Every donation to the Heart Research Institute is an investment into the lives of millions. Help make a lasting difference by donating today.

Other ways you can help

Your wellbeing is important. Here are...

Stay fit and active at home